Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07644858 · ClinicalTrials.gov registry record
MammoVerse: Breast Cancer Sexual Health Focus Groups
A clinical trial, sponsored by University of Central Florida.
- Completed
- Registry status
- 24
- Enrollment target
NCT07644858: Completed study, sponsored by University of Central Florida.
NCT07644858 is a clinical trial that has completed, run by University of Central Florida. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07644858 has completed, sponsored by University of Central Florida.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to explore the lived experiences, emotional challenges, and coping processes related to changes in sexual health and intimacy among women diagnosed with breast cancer. Insights gained from participants' personal experiences will provide a deeper understanding of patients' informational, emotional, and relational support needs, which will inform the development of an AI-driven digital support platform aimed at delivering personalized education, facilitating communication, and improving overall quality of life among women living with and beyond breast cancer in Florida. The study involves focus group discussions conducted via Zoom and online questionnaires administered to breast cancer patients and survivors.
Primary Outcome
To explore how women with breast cancer experience, interpret, and cope with changes in sexual health, intimacy, body image, and partner relationships, and to extract themes that capture shared patterns in lived experiences across participants. This qualitative exploration will employ grounded theory methods to understand intimacy related changes and coping processes in the context of cancer diagnosis and treatment.
Interventions
- OTHER Questionnaires and Focus Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2026-03-12 |
| Est. Completion | 2026-06-05 |
What the finished NCT07644858 record still lists
NCT07644858 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Questionnaires and Focus Group is the first listed.
NCT07644858 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07644858 about?
NCT07644858 is a clinical study titled "MammoVerse: Breast Cancer Sexual Health Focus Groups". The purpose of this study is to explore the lived experiences, emotional challenges, and coping processes related to changes in sexual health and intimacy among women diagnosed with breast cancer. Insights gained from participants' personal experiences will provide a deeper understanding of patients...
What is the current status of trial NCT07644858?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2026-03-12. Estimated completion is 2026-06-05.
What interventions are being tested in trial NCT07644858?
The interventions under investigation include: Questionnaires and Focus Group (OTHER).
Who is sponsoring clinical trial NCT07644858?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI